Stocks Screener

Search any stock or ticker

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

How This Company Makes Money

Dividend Analysis 0Q1N

Eagle - 15+ consecutive years of dividend increases

Max Ratio

9.70

Dividend Yield

6.69 %

5Y Dividend Growth

17.00 %

Consecutive Years

16 years

5Y Average Payout Ratio

147.81 %

Dividend History 0Q1N

1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021
Forward Annual Dividend Yield 6.69 %
Consecutive Years 16
Forward Annual Dividend 1.72 USD
Consistent Years 16
Dividend CAGR 3Y 2.50 %
Continuous Dividends
Dividend CAGR 5Y 3.13 %
Payout Ratio TTM 99.54 %
Dividend CAGR 10Y 4.91 %
Ex Dividend Date 11/07/2025

The 5 Pillars Formula Checklist

The Five-Pillar Secret Formula Checklist is our simple, proven way to separate strong, lasting businesses from the rest. We look at five key pillars—sales growth, profit growth, Net Income, dividend safety, and debt levels. Together with Financial Score, they tell us if a company can keep growing, stay financially solid, and reliably pay dividends for decades.

Sales Growth 0Q1N

Sales Growth – The Foundation of a Strong Business. Consistent revenue growth over the past 10-15 years is a key sign of a thriving company. It shows that demand for its products and services is increasing, allowing it to expand operations, gain market share, and invest in future growth.
1 year
3 years
5 years
10 years

Profit Growth / Profit Margin 0Q1N

The Fuel for Company Growth. Revenue alone isn’t enough—what truly matters is how efficiently a company turns that revenue into consistent, growing profits. Profitability is the foundation of sustainable growth and long-term financial strength.
1 year
3 years
5 years
10 years

Net Income 0Q1N

The True Measure of Financial Strength. Net income is what remains after all expenses, taxes, and costs. This is the company’s real earning power.
1 year
3 years
5 years
10 years

Payout Ratio TTM 0Q1N

Dividend Payout Safety – Protecting Your Passive Income. A high dividend yield is meaningless if the company can’t afford to sustain it. We evaluate payout ratios to ensure the company is not overextending itself. The best companies have a balanced approach—paying generous dividends while still reinvesting in future growth. Dividend safety is crucial for long-term income stability.
1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021

Debt Ratio 0Q1N

Debt Burden – Avoiding Financial Traps. Too much debt can cripple a company, even if its revenues and profits look great. We analyze how well a company manages its liabilities, ensuring that debt levels are under control.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021

Full Financial Performance

See how the company makes money over time—revenue, profits, dividends, and more. The charts on the right give you a quick view of growth trends so you can instantly spot consistency or red flags.

Pfizer Inc 0Q1N

1 year
3 years
5 years
10 years
Results 2019 Dynamics
* The data for this period has not yet been published

Bottom Line

Valuation Check

Shows if a stock is priced fairly by looking at peers and the company’s own history — a quick way to see if it’s a bargain or overpriced.

Value vs Peers

The company is measured against at least 10 rivals in the same sector. If it earns 25% more profit per share than the average, it’s Undervalued. If it earns 25% less, it’s Overvalued. In short: stronger earnings per share mean you’re getting a bargain, weaker ones mean you’re overpaying.

Value vs Itself 0Q1N

P/E shows how many dollars investors pay in the stock price for each $1 of profit the company earns per share. Today’s P/E is compared with the company’s 10-year average. If the ratio is above that norm, you’re paying up for each dollar of profit. If it’s below, you’re getting more earnings for less.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021
Trailing PE 14.87
Forward PE 8.34
Enterprise Value Revenue 3.02
Price Sales TTM 2.32
Enterprise Value EBITDA 10.22
Price Book MRQ 1.55

Pfizer Inc Dividends: 6.69 % Yield, History, Payment Schedule

0Q1N
Current price
25.69 USD +0.11 USD (+0.45%)
Last closed 25.57 USD
ISIN US7170811035
Sector Healthcare
Industry Drug Manufacturers - General
Exchange London Exchange
Capitalization 145 383 538 688 USD
Yield for 12 month 0.00 %
1Y
3Y
5Y
10Y
15Y
0Q1N
11/21/2021 - 11/28/2021

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Advanced Highlights

Current Year

+63 627 000 000 USD

Last Year

+59 553 000 000 USD

Current Quarter

+16 654 000 000 USD

Last Quarter

+14 653 000 000 USD

Current Year

+41 846 000 000 USD

Last Year

+30 340 000 000 USD

Current Quarter

+12 482 000 000 USD

Last Quarter

+9 420 000 000 USD
EBITDA 24 458 999 808 USD
Operating Margin TTM 35.28 %
Price to Earnings 14.87
Return On Assets TTM 5.19 %
PEG Ratio 13.90
Return On Equity TTM 10.60 %
Wall Street Target Price 29.04 USD
Revenue TTM 62 784 999 424 USD
Book Value 16.32 USD
Revenue Per Share TTM
Dividend Share 1.70 USD
Quarterly Revenue Growth YOY -5.90 %
Dividend Yield 6.69 %
Gross Profit TTM 46 968 000 512 USD
Earnings per share 1.72 USD
Diluted Eps TTM 1.72 USD
Most Recent Quarter III 2025
Quarterly Earnings Growth YOY -21.30 %
Profit Margin 15.65 %

Technical Indicators 0Q1N

For 52 Weeks

19.83 USD 27.21 USD
50 Day MA 25.01 USD
Shares Short Prior Month 116 815 571
200 Day MA 24.56 USD
Short Ratio 1.52
Shares Short 130 660 363
Short Percent 2.30 %